Condition: Non Small Cell Lung Cancer Metastatic · Sponsor: University Medical Center Groningen
Patients with newly diagnosed stage IV non-oncogene addicted NSCLC, who are fit for systemic treatment and don't have any symptoms of brain disease will undergo an MRI of the brain to screen for brain disease.
This description comes directly from the study's public registry record.
F. Bensch, MD, PhD · 0031503616161 · f.bensch@umcg.nl
L.B.M. Hijmering, MD · 0031503616161 · l.b.m.hijmering-kappelle@umcg.nl
Always discuss trial participation with your own doctor first.
| University Medical Center Groningen | Groningen, Provincie Groningen, Netherlands | Recruiting |
| Maastricht UMC+ | Maastricht, Netherlands | Recruiting |
| Ommelander Ziekenhuisgroep | Scheemda, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05864794